Fujifilm Medical Systems U.S.A. announced Wednesday, March 7, that it will be unveiling its newest mammography workstation, the ASPIRE Bellus II, at two upcoming imaging conferences. The ASPIRE Bellus II will be on display at the National Consortium of Breast Centers (NCoBC) conference March 9-14 in Las Vegas and the Society of Breast Imaging (SBI) Symposium April 12-15, also in Las Vegas.
“With early detection as the leading defense against breast cancer it is crucial that radiologists are armed with the right technology to inform diagnoses,” Rob Fabrizio, director of strategic marketing, Digital Radiography and Women’s Health, for Fujifilm Medical Systems U.S.A. “The ASPIRE Bellus II, a one-stop workstation solution designed specifically for mammographic diagnosis, aims to streamline workflow and optimize image displays enabling radiologists to make a more precise diagnosis.”
The workstation received FDA approval in September 2017 and will start being shipped to customers this spring. Fujifilm will be at booth #809 at the NCoBC conference and booth #332 at the SBI Symposium.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.